Clinical Trial Update: Melatonin for Pulmonary Hypertension in Full Term Neonates [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating melatonin for pulmonary hypertension in full-term neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Ain Shams University | Conditions: Neonatal Diseases and Abnormalities, Neonatal Mortality | Phase 3 | Status: COMPLETED